Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: Results from 237 cases

Current Medical Research and Opinion

Volumn 24, Issue 4, 2008, Pages 1011-1015

  Izzo, Francesco ^a,b   Di Giacomo, Raimondo ^a   Falco, Paolo ^a   Piccirillo, Mauro ^a   Iodice, Rossana ^a   Orlando, Antonio Pio ^a   Aprea, Pasquale ^a   Cremona, Francesco ^a   Di Marzo, Massimiliano ^a   Idà, Domenico Nicola ^a   Mastro, Angelo A ^a   Curley, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE   (Italy)

Author keywords

Haemostatic matrix; Hepatic surgery; Post operative haemostasis; Topical

Indexed keywords

HEMOSTATIC AGENT; SEALANT;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; THERAPY EFFECT;

BLOOD LOSS, SURGICAL; FEMALE; GELS; HEMOSTASIS; HEPATECTOMY; HUMANS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; THROMBIN; TIME FACTORS;

EID: 42549109671     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X280392     Document Type: Article

References (14)

1. Holloway DS, Summaria L, Sandesara J, et al. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-7
2. Despotis GJ, Filos KS, Zoys TN, et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82:13-21
3. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;20:1402-5
4. Mammen EF. Coagulation abnormalities in liver disease. Hematol Oncol Clin North Am 1992;6:1247-57
5. Oz MC, Rondinone JF, Shargill NS. Floseal matrix: new generation topical hemostatic sealant. J Card Surg 2003;18:486-93
6. Oz M, Cosgrove III DM, Badduke BR, et al; for the Fusion Matrix Study Group. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 2000;69:1376-82
7. Reuthebuch O, Lachat ML, Vogt P, Schurr U, Turina M. FloSeal®: a new hemostyptic agent in peripheral vascular surgery. Vasa J Vasc Dis 2000;29:204-6
8. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin- based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 2002;16:286-93
9. Renkens Jr KL, Payner T, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 2001;26:1645-50
10. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol Head Neck Surg 2004;131:601-5
11. Richter F, Schnorr D, Deger S, et al. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal). Urology 2003;61:73-7
12. Jacobs JB. Use of FloSeal in endoscopic sinus surgery. Operative Techniques Otolaryngol - Head Neck Surg 2001;2:83-4
13. Gall RM, Witterick IJ, Shargill NS, Hawke M. Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent. J Otolaryngol 2002;5:271-4
14. Pugh RNH, Murray-Lyon IM, Dawson J-L, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9